Safety, Tolerability and Immunogenicity of INO-4700 for MERS-CoV in Healthy Volunteers

NCT04588428 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

192

Enrollment

INDUSTRY

Sponsor class

Conditions

Middle East Respiratory Syndrome Coronavirus (MERS-CoV)

Interventions

DRUG: INO-4700
DRUG: Placebo
DEVICE: CELLECTRA™ 2000
DRUG: INO-4700
DEVICE: CELLECTRA™ 2000

Sponsor

Inovio Pharmaceuticals

Collaborators

[object Object]